Whoop expands wearable technology into Medicare patient market
Performance tracking company Whoop has launched a pilot program for Medicare beneficiaries as it seeks to integrate consumer wearables into the clinical healthcare sector.
Whoop, a wearable technology company previously focused on athletic performance, is shifting its business model to target older demographics. The new 'Whoop Connected Care' program provides devices and blood pressure monitoring to Medicare beneficiaries aged 65 and older diagnosed with conditions such as hypertension and diabetes.
Chief Medical Officer Dr. Ami Bhatt stated that the initiative aims to provide clinicians with data between appointments, moving beyond simple fitness tracking. By pivoting toward chronic condition management, the company is positioning its devices to play a role in preventative healthcare, potentially tapping into the broader clinical market.
The expansion comes as the industry faces scrutiny regarding the distinction between wellness tools and regulated medical devices. While the FDA recently issued guidance allowing wellness devices more flexibility to monitor chronic condition physiology, clinical researchers remain cautious. Experts argue that until proprietary algorithms are independently validated, the practical clinical utility of this high-volume data remains in a 'twilight zone' between wellness and professional medicine.